Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Anti-Inflammatory Effect of Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drops in an Endotoxin-Induced Uveitis Model

  • Bermúdez, María José
  • García-Otero, Xurxo
  • Mondelo-García, Cristina
  • González, Francisco
  • Pérez-Fernández, Román
  • Avila, Leandro
  • Antúnez, José
  • González-Barcia, Miguel
  • Adán, Alfredo
  • Aguiar, Pablo
  • Otero Espinar, Francisco Javier
  • Fernández Ferreiro, Anxo
[Abstract] Background: Uveitis is an infrequent disease which constitutes a major cause of ocular morbidity. Correct management is essential, being corticosteroids its cornerstone. In case of contraindication to corticosteroids or treatment failure, the use of topical tacrolimus (TAC) could be an alternative which has already demonstrated safety and effectiveness in other ocular pathologies. However, TAC eye drops are not marketed, thus their elaboration must be carried out in Hospital Pharmacy Departments (HPDs). Methods: 32 Sprague-Dawley rats were divided into 4 groups of 8 rats each: (a) untreated healthy rats (Healthy); (b) untreated Endotoxin-Induced Uveitis model-rats (EIU); (c) EIU-rats treated with standard treatment of dexamethasone ophthalmic drops (DXM) and (d) EIU-rats treated with TAC-hydroxypropyl-β-cyclodextrin eye drops previously developed by our group (TAC-HPβCD). The mRNA expression levels of IL-6, IL-8, MIP-1α and TNF-α, quantitative analysis of leucocytes in aqueous humor and histological evaluation were performed. Results: TAC-HPβCD eye drops demonstrated to reduce ocular inflammation, expression of IL-6, TNF-α, MIP-1α and leukocyte infiltration in aqueous humor. Conclusions: TAC-HPβCD eye drops showed beneficial effect in EIU model in rats, positioning as an alternative for uveitis treatment in case of corticosteroids resistance or intolerance., This project was partially funded by Health Research Institute Carlos III (PI20/00719, RETICS RD16/0008/0003), FEDER, Axencia Galega Innovación (Grupos de Potencial Crecimiento IN607B2020/11 y Grupo de Referencia Competitiva ED431C2021/01) and Spanish Ministry of Science, Innovation and Universities (RTI2018-099597-B-100). X. García-Otero is grateful to the IDIS (Health Research Institute of Santiago de Compostela) for financing his predoctoral research fellowship. C. Mondelo-García and A. Fernández-Ferreiro are grateful to the Carlos III Health Institute for financing their personnel contracts: JR20/00026 and JR18/00014., Xunta de Galicia; IN607B2020/11, Xunta de Galicia; ED431C2021/01
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Differential Sensitivity of the on and off Visual Responses to Retinal Ischemia

  • Bermúdez, María José
  • González, Francisco
This is an accepted version of the following published document: Bermudez, M.A., Gonzalez, F., 2020. Differential sensitivity of the On and Off visual responses to retinal ischemia. Experimental Eye Research 191, 107906. https://doi.org/10.1016/j.exer.2019.107906, [Abstract] Retinal ischemia is a common condition that may lead into vision impairment and blindness. In this study, we evaluated changes separately in On and Off visual responses induced by retinal ischemia. To do this, reversible retinal ischemia was induced in anaesthetized rats by increasing the intraocular pressure until the eye fundus became whitish for either 30 or 60 min. Both electroretinogram (ERG) and multiunit neuronal activity in the superior colliculus (SC) were recorded simultaneously for at least 20 min before, during, and after ischemia. In addition, in normal eyes, intravitreal glycine (Gly) injections were performed to further investigate the mechanisms involved in this process. We found that collicular Off responses were more sensitive to ischemia than On responses. The Off response was the first one to decay at the time ischemia was induced and the last to recover after blood reperfusion. The duration of ischemia also differentially affected both responses. After 30 min of ischemia, 14% of SC recordings failed to recover Off responses. After 1 h of ischemia, the percentage of recordings that failed to recover Off responses increased to 50%. Post-ischemic ERGs remained unaltered in all cases. Intravitreal Gly injections caused suppression of Off responses in the SC. Higher doses caused suppression of both On and Off responses in the SC but with no effect on the ERG at the doses tested. In summary, Off responses were more sensitive than On responses to ischemia suggesting that different mechanisms drive the two types of responses. The recovery of transitory ischemia was not complete in the SC responses whereas the ERG remained unaltered, suggesting that retinal damage produced by ischemia is more prominent in ganglion cells. Our results provide critical information for understanding ischemia repercussions and visual processing in the early visual system., This work received financial support from ISCIII (RD16/0008/0003) cofunded by the European Regional Development Fund /FEDER) to FG, and by Centro Singular de Investigación de Galicia (Acreditación 2016‐2019, ED431G/05)., Xunta de Galicia; ED431G/05
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Development And Characterization Of A Tacrolimus/hydroxypropyl-β-cyclodextrin Eye Drop

  • Bermúdez, María José
  • Varela-Fernández, Rubén
  • García-Otero, Xurxo
  • Díaz Tomé, Victoria
  • Martín-Pastor, Manuel
  • González-Barcia, Miguel
  • Blanco Méndez, José
  • Mondelo-García, Cristina
  • González, Francisco
  • Aguiar, Pablo
  • Fernández Ferreiro, Anxo
  • Otero Espinar, Francisco Javier
[Abstract] Uveitis is a vision inflammatory disorder with a high prevalence in developing countries. Currently, marketed treatments remain limited and reformulation is usually performed to obtain a tacrolimus eye drop as a therapeutic alternative in corticosteroid-refractory eye disease. The aim of this work was to develop a mucoadhesive, non-toxic and stable topical ophthalmic formulation that can be safely prepared in hospital pharmacy departments. Four different ophthalmic formulations were prepared based on the tacrolimus/hydroxypropyl-β-cyclodextrin (HPβCD) inclusion complexes’ formation. Phase solubility diagrams, Nuclear Magnetic Resonance (NMR) and molecular modeling studies showed the formation of 1:1 and 1:2 tacrolimus/HPβCD inclusion complexes, being possible to obtain a 0.02% (w/v) tacrolimus concentration by using 40% (w/v) HPβCD aqueous solutions. Formulations also showed good ophthalmic properties in terms of pH, osmolality and safety. Stability studies proved these formulations to be stable for at least 3 months in refrigeration. Ex vivo bioadhesion and in vivo ocular permanence showed good mucoadhesive properties with higher ocular permanence compared to the reference pharmacy compounding used in clinical settings (t1/2 of 86.2 min for the eyedrop elaborated with 40% (w/v) HPβCD and Liquifilm® versus 46.3 min for the reference formulation). Thus, these novel eye drops present high potential as a safe alternative for uveitis treatment, as well as a versatile composition to include new drugs intended for topical ophthalmic administration., This research was partially supported by the Spanish Ministry of Science, Innovation and Universities (RTI2018-099597-B-100), the ISCIII (PI17/00940, RETICS Oftared, RD16/0008/0003 and RD12/0034/0017) and by Xunta de Galicia, grant numbers GPC2013/015 and GRC2017/015. X.G.-O. and R.V.-F. acknowledge the financial support of the IDIS (Health Research Institute of Santiago de Compostela) (predoctoral research fellowships). P.A. acknowledges the support of RYC-2015/17430 (Ramón y Cajal). A.F.-F. acknowledges the support received from the Instituto de Salud Carlos III (ISCIII) through its Juan Rodes grant (JR18/00014)., Xunta de Galicia; GPC2013/015, Xunta de Galicia; GRC2017/015